跳至主要内容
临床试验/ISRCTN32319326
ISRCTN32319326已完成不适用

The role of biotinidase activity and deoxy-sphingolipids in glycogen storage disease type 1 and other disorders of carbohydrate and lipid metabolism

niversity Hospital Zurich0 个研究点目标入组 40 人开始时间: 2017年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Over 16 years of age)
  • 2. Signed informed consent
  • 3. Diagnosis of Glycogen storage disease type 1, hypertriglyceridemia, diabetes mellitus or non-alcoholic fatty liver disease (NAFLD)
  • Healthy controls:
  • 1. Male or female aged 18 years and over
  • 2. Healthy, no chronic disease, no intercurrent disease at time of examination/blood draw, normal weight (BMI 19-25 kg/m2), no excessive alcohol consumption
  • 3. Signed informed consent

排除标准

  • 1. Contraindications on ethical grounds
  • 2. Hepatocellular carcinoma (GSD1)
  • 3. Women who are pregnant or breast feeding
  • Health Controls:
  • Any relevant chronic or intercurrent disease at the time of examination.

研究者

发起方
niversity Hospital Zurich

相似试验